Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large household reduces dementia mortality: A cross-sectional data analysis of 183 populations. | PLoS One | 2022 | 35239673 | PubTator, text mining | PubMed |
| Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR. | Graefes Arch Clin Exp Ophthalmol | 2022 | 35239009 | PubTator, text mining | PubMed |
| Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography. | J Diabetes Res | 2022 | 35237693 | PubTator, text mining | PubMed |
| The use of high resolution optical coherence tomography (HR-OCT) in the diagnosis of ocular surface masqueraders. | Ocul Surf | 2022 | 35231640 | PubTator, text mining | PubMed |
| Visual function tests for glaucoma practice - What is relevant? | Indian J Ophthalmol | 2022 | 35225508 | PubTator, text mining | PubMed |
| Artificial Intelligence for Glaucoma: Creating and Implementing Artificial Intelligence for Disease Detection and Progression. | Ophthalmol Glaucoma | 2022 | 35218987 | PubTator, text mining | PubMed |
| Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1. | Int J Mol Sci | 2022 | 35216120 | PubTator, text mining | PubMed |
| Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes. | Int J Mol Sci | 2022 | 35216089 | PubTator, text mining | PubMed |
| The Evolution of Pharmacological Activities Bouea macrophylla Griffith In Vivo and In Vitro Study: A Review. | Pharmaceuticals (Basel) | 2022 | 35215350 | PubTator, text mining | PubMed |
| Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines. | Pharmaceutics | 2022 | 35214160 | PubTator, text mining | PubMed |
| Diagnosis and Treatment of Primary Inflammatory Choriocapillaropathies (PICCPs): A Comprehensive Overview. | Medicina (Kaunas) | 2022 | 35208488 | PubTator, text mining | PubMed |
| Line-Field Confocal Optical Coherence Tomography Increases the Diagnostic Accuracy and Confidence for Basal Cell Carcinoma in Equivocal Lesions: A Prospective Study. | Cancers (Basel) | 2022 | 35205830 | PubTator, text mining | PubMed |
| Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging. | Ophthalmology | 2022 | 35202616 | PubTator, text mining | PubMed |
| From Light to Structure: Photo Initiators for Radical Two-Photon Polymerization. | Chemistry | 2022 | 35202499 | PubTator, text mining | PubMed |
| 3-D OCT angiographic evidence of Anti-VEGF therapeutic effects on retinal capillary hemangioma. | Am J Ophthalmol Case Rep | 2022 | 35198818 | PubTator, text mining | PubMed |
| Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta-Iodobenzylguanidine (mIBG). | Drug Metab Dispos | 2022 | 35197314 | PubTator, text mining | PubMed |
| The methyltransferase enzymes KMT2D, SETD1B, and ASH1L are key mediators of both metabolic and epigenetic changes during cellular senescence. | Mol Biol Cell | 2022 | 35196069 | PubTator, text mining | PubMed |
| Novel volumetric imaging biomarkers for assessing disease activity in eyes with PCV. | Sci Rep | 2022 | 35194070 | PubTator, text mining | PubMed |
| Modeling oxidative injury response in human kidney organoids. | Stem Cell Res Ther | 2022 | 35189973 | PubTator, text mining | PubMed |
| Clinical profile and retinal nerve fibre layer thickness of optic disc oedema patients at a tertiary care institute in North India. | Ther Adv Ophthalmol | 2022 | 35187402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=56